Intermuscular Coherence as a Biomarker for ALS | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intermuscular Coherence as a Biomarker for ALS	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Recruiting	Not stated	2026-02-09		NCT05104710

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Massachusetts General Hospital	758
National Institute of Neurological Disorders and Stroke (NINDS)	370
National Institutes of Health (NIH)	667
University of California, Irvine	157
University of Chicago	326
Washington University School of Medicine	475

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Massachusetts General Hospital	Boston	United States	1015
University of California Center for Clinical Research	Irvine	United States	1
University of Miami Miller School of Medicine	Miami	United States	28
Washington University Medical Center	St Louis	United States	6